drugset / Trial / NCT05068921
A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy
NaSingle-groupOpen-labelTreatment
Summary
A phase I clinical trial of tolerability and pharmacokinetics of TQB2858 injection in subjects with advanced malignancy.
Timeline
- Start
- 2021-12-09
- Primary completion
- 2023-05
- Completion
- 2023-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TQB2858 | Protein / enzyme biologic | 1800 mg | Intravenous |